Wegovy, Mounjaro: prescription of anti-obesity drugs extended to all doctors in France
Until now, the initial prescription for these medications had to be issued by a doctor specializing in endocrinology, diabetology, and nutrition. Renewals, however, could be issued by any doctor.
The French National Agency for Medicines (ANSM) announced this Friday, June 20, that any doctor will be able to prescribe, for initiation or renewal, the GLP-1 drugs Wegovy (semaglutide), Mounjaro (tirzepatide) and Saxenda (liraglutide) to treat obesity, starting June 23.
"This measure aims to facilitate more equitable access to these treatments, available only by prescription," the ANSM explained in a press release.
Until now, the initial prescription of these drugs had to be made by a doctor specializing in endocrinology-diabetology-nutrition, but renewals could be made by any doctor.
>> More information coming soon on BFMV.com.
BFM TV
